{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:28:47Z","timestamp":1794443327820,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fond National de la Recherche Scientific","doi-asserted-by":"publisher","award":["FC43775"],"award-info":[{"award-number":["FC43775"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fond National de la Recherche Scientific","doi-asserted-by":"publisher","award":["J.0169.21"],"award-info":[{"award-number":["J.0169.21"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.rpth.2024.102521","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:57:51Z","timestamp":1721649471000},"page":"102521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["In\u00a0vitro assessment of the risk of ABCB1-mediated drug\u2013drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines"],"prefix":"10.1016","volume":"8","author":[{"given":"Gwena\u00eblle","family":"Mahieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Sennesael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Pochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Haufroid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-3583","authenticated-orcid":false,"given":"Laure","family":"Elens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102521_bib1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjh.14714","article-title":"Current challenges and future prospects in oral anticoagulant therapy","volume":"178","author":"Czuprynska","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102521_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ctr.12873","article-title":"Direct oral anticoagulant considerations in solid organ transplantation: a review","volume":"31","author":"Salerno","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.rpth.2024.102521_bib3","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hlc.2019.10.011","article-title":"Atrial flutter and fibrillation following lung transplantation: incidence, associations and a suggested therapeutic algorithm","volume":"29","author":"Barnes","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.rpth.2024.102521_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/TP.0000000000001977","article-title":"Venous thromboembolism after adult lung transplantation: a frequent event associated with lower survival","volume":"102","author":"Ribeiro Neto","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.rpth.2024.102521_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trre.2014.12.005","article-title":"Deep vein thrombosis and pulmonary embolism after solid organ transplantation: an unresolved problem","volume":"29","author":"S\u00e1ez-Gim\u00e9nez","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.rpth.2024.102521_bib6","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.21037\/jtd-22-300","article-title":"Bleeding and thrombotic complications associated with anticoagulation prior to lung transplantation: a case series","volume":"14","author":"Shepherd","year":"2022","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.rpth.2024.102521_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13318-017-0434-x","article-title":"In\u00a0vitro comparison of the role of P-glycoprotein and breast cancer resistance protein on direct oral anticoagulants disposition","volume":"43","author":"Hodin","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.rpth.2024.102521_bib8","first-page":"88","article-title":"Reconsideration of interactions between direct oral anticoagulants and calcineurin inhibitors","volume":"8","author":"Labbani-Motlagh","year":"2020","journal-title":"J\u00a0Pharm Care"},{"key":"10.1016\/j.rpth.2024.102521_bib9","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporin A and FK506","volume":"268","author":"Saeki","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.rpth.2024.102521_bib10","series-title":"Highlights of prescribing information","year":"2011"},{"key":"10.1016\/j.rpth.2024.102521_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106682","article-title":"Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation","volume":"130","author":"Camporese","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.rpth.2024.102521_bib12","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.rpth.2024.102521_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13853","article-title":"Utilization of direct-acting oral anticoagulation in solid organ transplant patients: a national survey of institutional practices","volume":"34","author":"Lichvar","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.rpth.2024.102521_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091555","article-title":"ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines","volume":"9","author":"Dessilly","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102521_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep29559","article-title":"Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib","volume":"6","author":"Dessilly","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2024.102521_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/0929867013373903","article-title":"Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic","volume":"8","author":"Dantzig","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.rpth.2024.102521_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12959-018-0183-3","article-title":"Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study","volume":"16","author":"Sennesael","year":"2018","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2024.102521_bib18","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1600-6143.2012.04174.x","article-title":"A\u00a0randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients","volume":"12","author":"Alloway","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rpth.2024.102521_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-006-0357-8","article-title":"Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins","volume":"60","author":"Pawarode","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.rpth.2024.102521_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28622-4","article-title":"Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines","volume":"8","author":"Sennesael","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2024.102521_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2217\/pgs-2016-0005","article-title":"Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study","volume":"17","author":"De Meyer","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.rpth.2024.102521_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/00498250500136676","article-title":"Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport","volume":"35","author":"Yamazaki","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.rpth.2024.102521_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijpharm.2014.02.020","article-title":"Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats","volume":"465","author":"Zhu","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.rpth.2024.102521_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.phrs.2016.05.012","article-title":"Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin","volume":"110","author":"Sauzay","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.rpth.2024.102521_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rpth.2024.102521_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/FTD.0000000000000356","article-title":"Effect of the direct oral anticoagulants rivaroxaban and apixaban on the disposition of calcineurin inhibitors in transplant recipients","volume":"39","author":"Vanhove","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.rpth.2024.102521_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bcp.12075","article-title":"Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects","volume":"76","author":"Mueck","year":"2013","journal-title":"Br J Clin Pharmacol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:04:53Z","timestamp":1794441893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2475037924002164"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102521","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro assessment of the risk of ABCB1-mediated drug\u2013drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102521"}}